skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

About Laurie


+12 year(s) experience

Laurie Withington provides insight to clients on our products, so they can use them to their fullest extent. She works mainly in the therapeutic areas of CNS, autoimmune, ophthalmology and oncology.

Laurie maintains and updates the products she works on, mainly Trialtrove and Analytics, and provides insight
and analysis in blogs and whitepapers on various diseases.

She initially worked in the Trialscape group when she joined Informa in 2008, providing custom analytics
projects to clients. Following this, she worked in the Trialtrove group in oncology, as well as in CNS,
autoimmune, and ophthalmology.

Before joining Informa, Laurie was a Cardiovascular/Metabolic Disease Portfolio Manager at Wyeth Pharma,
where she managed the risk, potential success, and logistics of the drugs in pipeline leading up to Phase I.

Analyst Articles

Articles by Laurie

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Clinical Research on the Wearable Technology Bandwagon

    Clinical Research on the Wearable Technology Bandwagon

    The wearable technology market is rapidly growing, and impacting many different areas of our culture such as social interaction, entertainment, environment, self-awareness, and healthcare. Techcrunch has forecasted sales of wearable devices worldwide this year at $30.5BN in total revenue . As more money is spent on wearable devices, innovation expands, which in turn increases the many facets of our lives that these devices can be incorporated into.

    Topic clinical-trials